The European Union fined Israel’s Teva Pharmaceutical 462.6 million euros, saying it abused its market position in a way that might have delayed competitors from entering the multiple sclerosis market.
Related Posts
Unilever Backs Outlook After Sales Growth
The consumer goods giant reiterated its full-year guidance after underlying sales grew more than expected in the third quarter as shoppers welcomed easing price hikes […]
The White-Collar Hiring Rut Is Here. That’s Bad News for Young College Grads.
After a pandemic boom, hiring is down for jobs that require a bachelor’s degree. ‘These companies just got way, way too bloated.’
Energy & Utilities Roundup: Market Talk
Find insight on Tullow Oil and more in the latest Market Talks covering Energy and Utilities.